about 1 month ago

Tom Brady Faces Backlash Over GLP-1 Weight-Loss Drug Endorsement

Tom Brady has become the latest athlete to promote GLP-1 weight-loss drugs after being named Chief Wellness Officer for eMed Population Health, a company expanding access to medications like Ozempic and Zepbound. The move sparked backlash from health experts, including entrepreneur Foster Coulson, who accused Brady of prioritizing profit over people and questioned using an elite athlete to market weight-loss injections.